Inpixon [INPX] vs Ceridian HCM Holding [CDAY] Detailed Stock Comparison

Inpixon

NASDAQ
Loading...

Ceridian HCM Holding Inc

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Inpixon wins in 3 metrics, Ceridian HCM Holding Inc wins in 13 metrics, with 0 ties. Ceridian HCM Holding Inc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Inpixon Ceridian HCM Holding Inc Better
P/E Ratio (TTM) -0.06 2,317.33 Ceridian HCM Holding Inc
Price-to-Book Ratio 16.71 4.55 Ceridian HCM Holding Inc
Debt-to-Equity Ratio 1.47 0.52 Ceridian HCM Holding Inc
EV/EBITDA -24.91 43.89 Ceridian HCM Holding Inc
Profit Margin (TTM) 71.73% 42.71% Inpixon
Operating Margin (TTM) -226.98% 8.73% Ceridian HCM Holding Inc
EBITDA Margin (TTM) N/A 8.73% N/A
Return on Equity -247.77% 2.29% Ceridian HCM Holding Inc
Return on Assets (TTM) -138.06% 0.61% Ceridian HCM Holding Inc
Free Cash Flow (TTM) $-35.16M $105.10M Ceridian HCM Holding Inc
1-Year Return 7.74% 7.43% Inpixon
Price-to-Sales Ratio (TTM) 20.01 7.23 Ceridian HCM Holding Inc
Enterprise Value $383.26M $11.61B Ceridian HCM Holding Inc
EV/Revenue Ratio 19.74 7.67 Ceridian HCM Holding Inc
Gross Profit Margin (TTM) 77.63% 42.48% Inpixon
Revenue per Share (TTM) $8 $10 Ceridian HCM Holding Inc
Earnings per Share (Diluted) $-34.12 $0.35 Ceridian HCM Holding Inc

Inpixon vs Ceridian HCM Holding Inc Stock Performance Analysis

Loading Price Chart...

INPX
CDAY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Inpixon-5.88%2.67%1.05%-20.66%28.00%34.27%
Ceridian HCM Holding Inc1.36%0.76%0.75%1.70%26.70%0.85%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Inpixon7.74%-36.49%-36.49%-36.49%-36.49%-36.49%
Ceridian HCM Holding Inc7.43%-8.86%-28.50%128.90%128.90%128.90%

Performance & Financial Health Analysis: Inpixon vs Ceridian HCM Holding Inc

MetricINPXCDAY
Market Information
Market Cap i$388.60M$10.94B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,641,7316,488,133
90 Day Avg. Volume i2,693,9393,844,351
Last Close$1.92$69.86
52 Week Range$1.22 - $7.43$48.01 - $72.28
% from 52W High-74.16%-3.35%
All-Time High$7.43 (Jun 11, 2025)$130.37 (Nov 01, 2021)
% from All-Time High-74.16%-46.41%
Growth Metrics
Quarterly Revenue Growth-0.02%0.06%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.72%0.43%
Operating Margin (TTM) i-2.27%0.09%
Return on Equity (TTM) i-2.48%0.02%
Debt to Equity (MRQ) i1.470.52
Cash & Liquidity
Book Value per Share (MRQ)$0.12$15.35
Cash per Share (MRQ)N/AN/A
Operating Cash Flow (TTM) i$-60,039,000$239.80M
Levered Free Cash Flow (TTM) i$-79,570,000$54.80M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Inpixon vs Ceridian HCM Holding Inc

MetricINPX (Apr 07, 2026)CDAY (Feb 17, 2026)
Price Ratios
P/E Ratio (TTM) i-0.062,317.33
Forward P/E i-0.0741.63
PEG Ratio iN/AN/A
Price to Sales (TTM) i20.017.23
Price to Book (MRQ) i16.714.55
Market Capitalization
Market Capitalization i$388.60M$10.94B
Enterprise Value i$383.26M$11.61B
Enterprise Value Metrics
Enterprise to Revenue i19.747.67
Enterprise to EBITDA i-24.9143.89
Risk & Other Metrics
Beta iN/AN/A
Book Value per Share (MRQ) i$0.12$15.35

Financial Statements Comparison: Inpixon vs Ceridian HCM Holding Inc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricINPX (2022)CDAY (2023)
Revenue/Sales i19.42M1.51B
Cost of Goods Sold i5.49M867.20M
COGS % of Revenue i28.3%57.3%
Gross Profit i13.93M646.50M
Gross Margin i71.7%42.7%
Research & Development i17.66MN/A
Operating Income (EBIT) i-44.08M133.10M
Operating Margin i-227.0%8.8%
EBITDA i-15.38M264.60M
EBITDA Margin i-79.2%17.5%
Pre-Tax Income i-66.37M96.00M
Pre-Tax Income % of Revenue i-341.8%6.3%
Income Tax i-65,00041.20M
Income Tax % of Revenue i-0.3%2.7%
Net Income (Profit) i-66.30M54.80M
Profit Margin i-341.5%3.6%

Balance Sheet & Liquidity Metrics

MetricINPX (2022)CDAY (2023)
Cash & Equivalents i20.24M570.30M
Total Current Assets i29.87M5.96B
Total Current Assets % of Revenue i153.8%393.4%
Total Current Liabilities i24.71M5.33B
Total Current Liabilities % of Revenue i127.3%352.4%
Long-Term Debt i778,0001.23B
Long-Term Debt % of Revenue i4.0%81.2%
Total Shareholders Equity i32.12M2.40B
Retained Earnings i-314.84M-317.80M
Retained Earnings % of Revenue i-1,621.4%-21.0%
Property, Plant & Equipment i2.76M19.10M

Cash Flow Statement Comparison

MetricINPX (2022)CDAY (2023)
Operating Cash Flow i-60.04M239.80M
Operating Cash Flow % of Revenue i-309.2%15.8%
Capital Expenditures i-245,000N/A
Free Cash Flow i-35.16M105.10M
FCF Margin i-181.0%6.9%
Debt Repayment iN/A-7.90M
Common Stock Repurchase i-102.45MN/A

Short Interest & Institutional Ownership Analysis

MetricINPXCDAY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i194.30M156.60M
Float Shares iN/AN/A
% Held by Insiders iN/AN/A
% Held by Institutions iN/AN/A
% Held by Public iN/AN/A

Dividend Analysis & Yield Comparison: Inpixon vs Ceridian HCM Holding Inc

MetricINPXCDAY
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A